A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Clinical trial NCT02981472 · COMPLETED
Trial details
- NCT number
- NCT02981472
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2021-10-18
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.